Clinical OMICS

MAY-JUN 2017

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: http://clinicalomics.epubxp.com/i/827649

Contents of this Issue

Navigation

Page 31 of 47

30 Clinical OMICs May/June 2017 www.clinicalomics.com Data & Informatics A n ambitious effort has begun to decipher the genes and proteins making up the human immune sys- tem, and determine how they work. The Human Vaccines Project—a non- profit public-private partnership— and Vanderbilt University Medical Center are using the sequencing tools and analysis expertise of Illumina to support one of the Project's two key programs, the Human Immunome Program, which aims to reveal for the first time the specific components of the human immune system, which prevent and control disease. One hundred individuals will be studied within the next two years, a number set to grow to about 1,000 over an estimated five years. The Program has already completed preliminary analysis of the first three individuals, to refine the large-scale sequencing and complex bioinformatics strategies required for the program. The Program will sequence the receptors of B and T immune cells from individuals of diverse ages, gen- ders, genetics, geography, and disease states and results will be shared with researchers worldwide through an open-source database. To date, researchers have collected samples from the first three partici- pants, using leukapheresis to harvest some 40 billion blood B cells. The study sequenced all the genes of the B-cell and T-cell receptors from these indi- viduals. "The idea is to get a complete col- lection of all the immune genes that they're using from their B and T cells. Now we have billions of sequences from each of the three individuals," James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center and lead investigator of the Human Immunome Program, told Clinical OMICs. "Based on these preliminary studies, we're refining our approach and will soon be enrolling the next 7 to 10 persons into the study." The Program is attempting to iden- tify and catalogue the principal com- ponents of the human immune system at the genetic level of healthy individ- Immune Investigators Human Immunome Program Seeks Insights on Preventing and Controlling Disease Alex Philippidis, Senior News Editor The Human Immunome Project expects to enroll 1,000 people within the next five years. "The idea is to get a complete collection of all the immune genes that they're using from their B and T cells. Now we have billions of sequences from each of the three individuals." —James Crowe Jr., M.D. Vanderbilt Vaccine Center

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2017